Progress in the Development of a Breast Cancer Vaccine: Mammaglobin A as an Attractive Target for Vaccine Therapy
作者： William E. Gillanders , Thalachallour Mohanakumar
DOI: 10.1016/S1043-321X(06)80323-1
关键词: Vaccine therapy 、 Oncology 、 Breast cancer 、 Medicine 、 Mammaglobin-A 、 Internal medicine
摘要:
sci-hub.se 参考文章(14)
John DiPersio, Suzanne Dintzis, Christopher M. Darrow, Mark A. Watson, Timothy P. Fleming, Lora E. Voss, Roy Jensen, Mammaglobin Expression in Primary, Metastatic, and Occult Breast Cancer Cancer Research. ,vol. 59, pp. 3028- 3031 ,(1999)
Mark A. Watson, Timothy P. Fleming, Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Research. ,vol. 56, pp. 860- 865 ,(1996)
Steven A Rosenberg, James C Yang, Nicholas P Restifo, Cancer immunotherapy: moving beyond current vaccines Nature Medicine. ,vol. 10, pp. 909- 915 ,(2004) , 10.1038/NM1100
Partha P. Manna, Andrés Jaramillo, Kanchana Majumder, Lacey G. Campbell, Timothy P. Fleming, Jill R. Dietz, John F. Dipersio, T. Mohanakumar, Generation of CD8+ Cytotoxic T Lymphocytes Against Breast Cancer Cells by Stimulation with Mammaglobin-A-Pulsed Dendritic Cells Breast Cancer Research and Treatment. ,vol. 79, pp. 133- 136 ,(2003) , 10.1023/A:1023323509888
Andr�s Jaramillo, Kanchana Majumder, Partha P. Manna, Timothy P. Fleming, Gerard Doherty, John F. Dipersio, Thalachallour Mohanakumar, Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer. International Journal of Cancer. ,vol. 102, pp. 499- 506 ,(2002) , 10.1002/IJC.10736
George E. Peoples, Jennifer M. Gurney, Matthew T. Hueman, Mike M. Woll, Gayle B. Ryan, Catherine E. Storrer, Christine Fisher, Craig D. Shriver, Constantin G. Ioannides, Sathibalan Ponniah, Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients Journal of Clinical Oncology. ,vol. 23, pp. 7536- 7545 ,(2005) , 10.1200/JCO.2005.03.047
L A Emens, R T Reilly, E M Jaffee, Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity Endocrine-related Cancer. ,vol. 12, pp. 1- 17 ,(2005) , 10.1677/ERC.1.00671
Jeffrey A. Sosman, Joseph M. Unger, P.-Y. Liu, Lawrence E. Flaherty, Min S. Park, Raymond A. Kempf, John A. Thompson, Paul I. Terasaki, Vernon K. Sondak, Adjuvant Immunotherapy of Resected, Intermediate-Thickness, Node-Negative Melanoma With an Allogeneic Tumor Vaccine: Impact of HLA Class I Antigen Expression on Outcome Journal of Clinical Oncology. ,vol. 20, pp. 2067- 2075 ,(2002) , 10.1200/JCO.2002.08.072
Jan B Vermorken, Anke ME Claessen, Harm van Tinteren, Helen E Gall, Renate Ezinga, Sybren Meijer, Rik J Scheper, Chris JLM Meijer, Elizabeth Bloemena, Janet H Ransom, Michael G Hanna, Herbert M Pinedo, Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial The Lancet. ,vol. 353, pp. 345- 350 ,(1999) , 10.1016/S0140-6736(98)07186-4
Diane M Harper, Eduardo L Franco, Cosette Wheeler, Daron G Ferris, David Jenkins, Anne Schuind, Toufik Zahaf, Bruce Innis, Paulo Naud, Newton S De Carvalho, Cecilia M Roteli-Martins, Julio Teixeira, Mark M Blatter, Abner P Korn, Wim Quint, Gary Dubin, Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial The Lancet. ,vol. 364, pp. 1757- 1765 ,(2004) , 10.1016/S0140-6736(04)17398-4